TITLE

Modelling survival in cystic fibrosis

AUTHOR(S)
Corey, M.
PUB. DATE
October 2001
SOURCE
Thorax;Oct2001, Vol. 56 Issue 10, p743
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article focuses on cystic fibrosis. It introduces papers published in the October 1, 2001 issue of the journal "Thorax," which are related to prognosis or treatment for cystic fibrosis (CF) in the past two decades. The author states that the upward trend in the expected duration of life for patients with CF may have lost its momentum. The U.S. and Canadian national CF registries show estimated median survival age increasing to around 32 years in 1989 and 1996, respectively, but in subsequent years no further improvement is seen. Although the timing of a plateau in median survival age may differ, consistent patterns are seen in several other population-based studies.
ACCESSION #
12991405

 

Related Articles

  • Pseudomonas eradication in cystic fibrosis: who will join the ELITE? Smyth, Alan R. // Thorax;Apr2010, Vol. 65 Issue 4, p281 

    The author reflects on the study by F. Ratjen and colleagues regarding eradication of the bacteria Pseudomonas aeruginosa in patients with cystic fibrosis (CF). The author says that the study, published in the April 2010 issue of the journal "Thorax," has offered the first eradication treatment...

  • Information needs of young people with cystic fibrosis. Hinton, Shona; Watson, Sylvia; Chesson, Rosemary; Mathers, Sandra // Paediatric Nursing;Jul2002, Vol. 14 Issue 6, p18 

    Discusses the importance of involving young people with cystic fibrosis in reviewing information materials. Significance of involving patients in decisions about their care and treatment; Information on cystic fibrosis; Recommendations for practice.

  • Multiple-breath inert gas washout test and early cystic fibrosis lung disease. Aurora, P. // Thorax;May2010, Vol. 65 Issue 5, p373 

    The author reflects on multiple-breath inert gas washout (MBW) test and its use for monitoring the development of cystic fibrosis (CF) lung disease. He says that MBW, which can be performed using either a resident marker gas or an inhaled marker gas, describes the changes in exhaled tracer gas...

  • CF: Not just a pediatric problem anymore. George, Maureen Redmond; Mauro, Elizabeth // RN;Sep90, Vol. 53 Issue 9, p60 

    Discusses the care and support available for adults with cystic fibrosis. Average age of survival for cystic fibrosis patients; Complications of cystic fibrosis; Treatment for cystic fibrosis.

  • Republished editorial: Following Nero: fiddle while Rome burns, or is there a better way? Bush, Andrew; Pavord, Ian // Postgraduate Medical Journal;Oct2011, Vol. 87 Issue 1032, p657 

    A reprint of the article "Following Nero: Fiddle While Rome Burns, or Is There a Better Way?," by Andrew Bush and Ivan Pavord, which appeared in the May 2011 issue of "Thorax" is presented. It focuses on the use of the term "exacerbation" when describing lung attack and other lung diseases like...

  • Preventing hyponatraemic dehydration in cystic fibrosis: a cautionary note to take coconut water with a pinch of salt. Sayer, Rebecca; Sinha, Ian; Lowdon, Jacqueline; Panickar, Jay // Archives of Disease in Childhood;Jan2014, Vol. 99 Issue 1, p90 

    The article discusses the use of coconut water with salt to prevent hyponatraemic dehydration in cystic fibrosis (CF). It examines the content of a leading brand of coconut water in Great Britain containing sodium, potassium, and dioralyte. It proposes avoiding coconut water for maintaining...

  • Study Results Raise Hope for CF Therapy That Targets the Underlying Cause. Evans, Frederique H. T. // Pulmonary Reviews;Dec2011, Vol. 16 Issue 12, p1 

    The article discusses a clinical trial which suggests that ivacaftor, a cystic fibrosis transmembrane conductane regulator (CFTR), helped improve lung function at two weeks and through 48 weeks of therapy among patients with cystic fibrosis (CF) with G551D-CFTR mutation. Patients taking...

  • Effect of elective antibiotic therapy on resting energy expenditure and inflammation in cystic fibrosis. Burdet, L.; Hugli, O.; Aubert, J. D.; Schutz, Y.; Roulet, M.; Fitting, J. W. // European Journal of Pediatrics;1999, Vol. 158 Issue 9, p711 

    Abstract Cystic fibrosis (CF) patients often present with malnutrition which may partly be due to increased resting energy expenditure (REE) secondary to inflammation. Both REE and tumour necrosis factor-alpha (TNF-alpha), as other markers of inflammation, are elevated during respiratory...

  • Azithromycin.  // Reactions Weekly;1/21/2017, Vol. 1635 Issue 1, p55 

    An abstract of the article "Incidence of ventricular arrhythmias in cystic fibrosis patients treated with chronic azithromycin therapy and other qt prolonging drugs" by A.K. Tripathi and others is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics